Yuka Uesugi
Overview
Explore the profile of Yuka Uesugi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narita H, Kuroiwa K, Kawaguchi Y, Murai S, Sasaki Y, Homma M, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456838
Most follicular lymphomas (FLs) demonstrate an indolent clinical course with favorable outcomes; however, a fraction of patients experiences progression of disease within 24 months (POD24) and has adverse outcomes. This...
2.
Fujioka H, Nakashima K, Uesugi Y, Nyui M, Inoshima N, Hayashi J, et al.
Respir Med Case Rep
. 2024 Oct;
52:102115.
PMID: 39376643
Intravascular large B-cell lymphoma (IVLBCL) typically involves nonspecific symptoms that complicate diagnosis. This report discusses the case of a 70-year-old man, who presented with dyspnea, fatigue, and weight loss that...
3.
Kuroiwa K, Sato M, Narita H, Okamura R, Uesugi Y, Sasaki Y, et al.
Int J Hematol
. 2024 Feb;
119(5):583-591.
PMID: 38418747
The impact of FOXP3 single-nucleotide polymorphisms (SNP) on clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains poorly understood. We investigated the relationship between a FOXP3 SNP (rs3761548) and...
4.
Shimada S, Kuroiwa K, Narita H, Okamura R, Uesugi Y, Sasaki Y, et al.
Rinsho Ketsueki
. 2024 Feb;
65(1):24-29.
PMID: 38311385
Immune checkpoint inhibitor (ICI)-induced thrombocytopenias are rare immune-related adverse events (irAE), but ICI-related thrombotic thrombocytopenic purpura (TTP) is extremely rare. A 79-year-old woman with non-small cell lung cancer received maintenance...
5.
Uesugi Y, Ikeda D, Fukumoto A, Tabata R, Miura D, Narita K, et al.
Haematologica
. 2023 Nov;
109(5):1593-1597.
PMID: 38031801
No abstract available.
6.
Ikeda D, Fukumoto A, Uesugi Y, Tabata R, Miura D, Narita K, et al.
Blood Cancer J
. 2023 Sep;
13(1):133.
PMID: 37666820
No abstract available.
7.
Fukumoto A, Honma K, Nakaminato S, Kitaura K, Ikeda D, Uesugi Y, et al.
Transplant Cell Ther
. 2023 Jul;
29(10):639.e1-639.e4.
PMID: 37423340
The aim of this study was to evaluate the concordance between clinical diagnosis and pathologic findings of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in post-hematopoietic stem cell transplantation recipients and to...
8.
Fukumoto A, Narita K, Ikeda D, Uesugi Y, Tabata R, Miura D, et al.
Jpn J Clin Oncol
. 2023 Jul;
53(10):991-995.
PMID: 37394913
Venetoclax combined with low-intensity chemotherapy has led to longer survival and higher remission rates in patients with untreated acute myeloid leukaemia who are ineligible for intensive chemotherapy. We reviewed 41...
9.
Narita K, Ikeda D, Seki M, Fukumoto A, Tabata R, Uesugi Y, et al.
Hemasphere
. 2023 Jun;
7(6):e905.
PMID: 37292116
No abstract available.
10.
Sasaki Y, Murai S, Okamura R, Uesugi Y, Shimada S, Watanuki M, et al.
Rinsho Ketsueki
. 2023 Feb;
64(1):42-48.
PMID: 36775306
A 75-year-old man who had lymphadenopathy was admitted to our hospital. Histopathological examination of cervical lymph node biopsy specimens showed diffuse proliferation of lymphoma cells with large nuclei. In immunohistochemistry,...